Last checked at 
15 Aug 2018 14:01
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the Company) notes the following unquoted portfolio event.
The Company has received quarterly investor reporting in relation to its investment in the unlisted venture capital fund, SV Fund VI.
SV Fund VI's latest quarterly investor report values the Company's investment at $25.0m (£19.6m), an uplift of $3.4m (£2.7m) on the valuation of $21.6m (£16.9m) which was included in the Company's Net Asset Value (NAV) calculation for 13 August 2018.
In line with the Company's accounting policy, valuation movements following receipt of quarterly investor reports are reflected in the next reported NAV. Therefore, the increase in NAV to be reported today, as at 14 August 2018, will be £2.7m or 7.2 pence per share.
Enquiries:
Kate Bingham/Carl Harald Janson
Telephone: 020 7421 7070
SV Health Managers LLP
Investment Manager
15 August 2018